\-\ Texto\\:\\ \ \(0\)\
\-\ height\\:\\ 5\\&\\#39\\;3\\"\\ weight\\:\\ 232\\ lbs\ \(0\)\
\-\ bp\\:\\ 115\\/80\\ hr\\:\\ 84\\ rr\\:12\ \(0\)\
\-\ abdomen\\ tender\\ to\\ palpation\\ in\\ both\\ lower\\ quadrants\\.\\ no\\ palpable\\ masses\\ appreciated\\.\ \(0\)\
\-\ on\\ her\\ transvaginal\\ us\\,\\ bilateral\\ dermoid\\ cysts\\ was\\ suspected\\ as\\ well\\ as\\ a\\ larger\\ mass\\.\\ subsequent\\ ct\\ confirmed\\ bilateral\\ dermoid\\/teratoma\\ cysts\\ as\\ well\\ as\\ a\\ large\\ fibroid\\ causing\\ displacement\\ of\\ the\\ right\\ ovary\\.\\ \ \(0\)\
\-\ in\\ cases\\ where\\ the\\ dermoids\\ are\\ \\<6cm\\,\\ they\\ can\\ be\\ followed\\ with\\ serial\\ imaging\\.\\ however\\,\\ if\\ symptomatic\\,\\ the\\ treatment\\ is\\ bilateral\\ simple\\ cystectomy\\.\ \(0\)\
\-\ ct\\ report\\:\ \(0\)\
\-\ ovaries\\ are\\ somewhat\\ prominent\\ in\\ size\\ bilaterally\\.\\ contains\\ well\\ circumscribed\\ areas\\ of\\ fat\\ density\\ as\\ well\\ as\\ faint\\ areas\\ of\\ increased\\ density\\ suggestive\\ of\\ teratoma\\.\\ the\\ right\\ ovary\\ projects\\ at\\ midline\\ superiorly\\ on\\ the\\ pelvic\\ ct\\ apparently\\ displaced\\ by\\ pedunculated\\ uterine\\ fibroid\\.\\ \\ on\\ review\\ it\\ is\\ noted\\ that\\ the\\ right\\ ovary\\ has\\ calcium\\/bone\\ within\\ it\\ and\\ might\\ be\\ better\\ understood\\ as\\ a\\ mature\\ teratoma\\.\\ \\ whereas\\,\\ the\\ left\\ ovary\\ does\\ not\\ demonstrate\\ the\\ finding\\ of\\ calcium\\/bone\\ in\\ the\\ same\\ manner\\ and\\ might\\ better\\ be\\ described\\ as\\ a\\ dermoid\\ cyst\\.\ \(0\)\
\-\ mature\\ cystic\\ teratoma\ \(11\)\
\-\ the\\ adnexa\\ refers\\ to\\ the\\ anatomical\\ region\\ adjacent\\ to\\ the\\ uterus\\ containing\\ the\\ fallopian\\ tube\\ and\\ the\\ uterus\\ and\\ includes\\ the\\ ligaments\\,\\ vessels\\ and\\ soft\\ tissue\\ surrounding\\ these\\ structures\\.\\ a\\ variety\\ of\\ pathology\\ can\\ arise\\ here\\.\\ the\\ differential\\ for\\ an\\ adnexal\\ mass\\ includes\\:\ \(0\)\
\-\ \\?\\ physiologic\\/functional\\ cysts\\ such\\ as\\ a\\ non\\-ruptured\\ follicle\\ causing\\ follicular\\ cysts\\)\ \(0\)\
\-\ \\?\\ leiomyoma\\ \\(fibroids\\)\\ though\\ typically\\ arising\\ from\\ the\\ uterus\\ can\\ also\\ be\\ found\\ in\\ the\\ broad\\ ligament\ \(0\)\
\-\ \\?\\ polycystic\\ ovarian\\ syndrome\ \(0\)\
\-\ \\?\\ pelvic\\ inflammatory\\ disease\\ causing\\ pyosalpinx\\,\\ hydrosalpinx\\,\\ abcesses\\,\\ past\\ scarring\\ \\(\\â\\€\\œclubbing\\â\\€\\\\ of\\ the\\ fimbriae\\)\ \(0\)\
\-\ \\?\\ benign\\ ovarian\\ neoplasms\\:\\ serous\\ and\\ mucinous\\ cystadenoma\\,\\ endometrioma\\,\\ mature\\ teratoma\ \(0\)\
\-\ \\?\\ malignant\\ ovarian\\ neoplasms\ \(0\)\
\-\ \\?\\ metastatic\\ carcinoma\\ such\\ as\\ krukenberg\ \(0\)\
\-\ \\?\\ neoplasms\\ arising\\ from\\ other\\ structures\\ such\\ as\\ the\\ broad\\ ligament\\ and\\ fallopian\\ tube\ \(0\)\
\-\ 31\\ yo\\ g1p1\\ woman\\,\\ had\\ us\\ done\\ for\\ locating\\ an\\ iud\\.\\ pt\\ states\\ she\\ has\\ had\\ pain\\ in\\ her\\ abdomen\\,\\ buttocks\\ and\\ lower\\ back\\ on\\ and\\ off\\ for\\ 2\\ months\\.\\ the\\ pain\\ is\\ sore\\ and\\ cramping\\ in\\ nature\\.\\ 2\\/10\\ at\\ rest\\,\\ 6\\/10\\ when\\ exacerbated\\ with\\ touch\\ or\\ sneezing\\.\\ the\\ pain\\ does\\ not\\ radiate\\.\\ it\\ is\\ worse\\ in\\ the\\ morning\\.\\ she\\ also\\ noticed\\ increase\\ in\\ menstrual\\ flow\\.\\ pt\\ attributed\\ these\\ symptoms\\ to\\ her\\ iud\\,\\ and\\ decided\\ to\\ change\\ types\\.\\ the\\ iud\\ was\\ unable\\ to\\ be\\ found\\ visually\\ on\\ physical\\ examination\\ in\\ the\\ office\\,\\ which\\ led\\ to\\ the\\ us\\.\\ subsequent\\ ct\\ was\\ done\\ to\\ confirm\\ us\\ findings\\.\\ \ \(0\)\
\-\ of\\ note\\,\\ approximately\\ 6\\ months\\ prior\\ to\\ these\\ images\\,\\ the\\ patient\\ was\\ hospitalized\\ for\\ acute\\ bleeding\\ and\\ a\\ rash\\.\\ she\\ was\\ diagnosed\\ with\\ idiopathic\\ thrombocytopenia\\.\\ she\\ was\\ transfused\\ and\\ stabalized\\,\\ and\\ discharged\\ after\\ a\\ 5\\ day\\ stay\\.\\ she\\ has\\ subsequently\\ followed\\ up\\ with\\ hematology\\ and\\ rheumatology\\,\\ and\\ was\\ given\\ a\\ course\\ of\\ prednisone\\ and\\ hydrochloroquine\\.\\ her\\ repeat\\ serial\\ cbcs\\ have\\ been\\ stable\\ and\\ she\\ has\\ remained\\ asymptomatic\\.\ \(0\)\
\-\ case\\ contributors\\:peter\\ tang\\,\\ msiii\\;\\ june\\ koshy\\,\\ md\\;\\ randall\\ loftus\\,\\ md\\;\\ joanna\\ garvey\\,\\ dc\\;\\ robert\\ lutnick\\,\\ md\\;\\ ashley\\ newbury\\,\\ dc\\;\\ scott\\ croce\\,\\ dc\\;\\ krishnan\\ kartha\\,\\ md\\;\\ joseph\\ serghany\\,\\ md\\;\\ charles\\ tirone\\ md\\,\\ vaseem\\ iqbal\\ md\\;\\ geoffrey\\ gerow\\,\\ dc\\.\\ \\ \\ \ \(0\)\
\-\ mature\\ cystic\\ teratomas\\ are\\ commonly\\ asymptomatic\\ and\\ are\\ only\\ found\\ on\\ incidental\\ imaging\\.\\ in\\ this\\ patient\\,\\ \\ it\\ is\\ likely\\ her\\ abdominal\\ pain\\ is\\ due\\ to\\ the\\ mass\\ effect\\ of\\ the\\ large\\ fibroid\\ displacing\\ her\\ ovaries\\ and\\ other\\ pelvic\\ structures\\.\\ any\\ pain\\ due\\ to\\ the\\ stretching\\ of\\ the\\ ligaments\\ would\\ be\\ exacerbated\\ by\\ jerky\\ movements\\ sudden\\ increase\\ in\\ pressure\\ such\\ as\\ sneezing\\.\\ the\\ patient\\ has\\ decided\\ to\\ undergo\\ attempted\\ laparoscopic\\ resection\\.\ \(0\)\
\-\ approximately\\ 6\\ months\\ prior\\ to\\ the\\ patient\\&\\#39\\;s\\ incidental\\ finding\\ of\\ her\\ mature\\ teratoma\\,\\ she\\ was\\ urgently\\ hospitalized\\ for\\ an\\ acute\\ onset\\ of\\ bleeding\\ and\\ rash\\.\\ she\\ initially\\ presented\\ with\\ epistaxis\\ and\\ also\\ a\\ rash\\ after\\ scratching\\ her\\ arm\\.\\ the\\ rash\\ was\\ described\\ as\\ flat\\ round\\ dots\\ and\\ very\\ dark\\.\\ \\ the\\ rash\\ spread\\ to\\ involve\\ her\\ lips\\,\\ fingertip\\ and\\ back\\ of\\ mouth\\.\\ as\\ her\\ rash\\ got\\ worse\\,\\ she\\ went\\ to\\ the\\ er\\ where\\ her\\ cbc\\ showed\\ a\\ platelet\\ count\\ of\\ 6\\,000\\.\\ subsequent\\ work\\ up\\ was\\ negative\\ and\\ she\\ was\\ diagnosed\\ with\\ idiopathic\\ thrombocytopenic\\ purpura\\ \\(itp\\)\\.\\ \\ itp\\ is\\ a\\ condition\\ where\\ there\\ is\\ immunologic\\ destruction\\ of\\ platetes\\,\\ due\\ to\\ the\\ formation\\ of\\ igg\\ to\\ various\\ antigens\\,\\ such\\ as\\ glycoprotein\\ iib\\/iiia\\.\\ pt\\ was\\ transfused\\ and\\ after\\ three\\ days\\ her\\ platelets\\ were\\ elevated\\ to\\ 114\\,000\\.\\ she\\ has\\ since\\ been\\ given\\ a\\ course\\ of\\ steroids\\ and\\ hydrochloroquine\\.\\ subsequent\\ hematology\\ and\\ rheumatology\\ followup\\ has\\ not\\ suggested\\ any\\ chronic\\ disease\\ contributing\\ to\\ her\\ episode\\ of\\ itp\\.\\ subsequent\\ cbcs\\ have\\ been\\ stable\\,\\ and\\ the\\ patient\\ remains\\ asymptomatic\\.\ \(0\)\
\-\ although\\ itp\\ has\\ never\\ been\\ associated\\ with\\ mature\\ cystic\\ teratomas\\ specifically\\,\\ there\\ have\\ been\\ case\\ reports\\ of\\ paraneoplastic\\ itp\\ associated\\ with\\ ovarian\\ cancer\\,\\ and\\ other\\ malignancies\\ such\\ as\\ breast\\,\\ and\\ lung\\ \\[1\\]\\.\\ it\\ has\\ been\\ suggested\\ that\\ malignancy\\ associated\\ itp\\ is\\ not\\ an\\ uncommon\\ occurrence\\ and\\ a\\ separate\\ classification\\ of\\ this\\ \\"secondary\\ itp\\"\\ should\\ be\\ considered\\.\\ because\\ malignant\\ transformation\\ is\\ unlikely\\ in\\ classic\\ mature\\ cystic\\ teratomas\\,\\ and\\ lack\\ of\\ research\\ in\\ this\\ area\\,\\ it\\ is\\ not\\ clear\\ that\\ in\\ this\\ patient\\ her\\ itp\\ is\\ of\\ an\\ analogous\\ paraneoplastic\\ etiology\\.\\ \ \(0\)\
\-\ however\\,\\ there\\ have\\ been\\ two\\ reported\\ autoimmune\\ paraneoplastic\\ syndromes\\ associated\\ with\\ mature\\ cystic\\ teratomas\\:\\ autoimmune\\ hemolytic\\ anemia\\ \\(aiha\\)\\,\\ and\\ anti\\-nmda\\ receptor\\ encephalitis\\ \\[2\\-3\\]\\.\\ aiha\\ is\\ similar\\ to\\ itp\\ in\\ that\\,\\ the\\ mechanism\\ involves\\ igg\\ \\(or\\ igm\\,\\ iga\\)\\ formation\\ vs\\ rbc\\ antigens\\ such\\ as\\ rh\\ factor\\.\\ interestingly\\,\\ in\\ the\\ reported\\ cases\\ of\\ aiha\\,\\ a\\ portion\\ of\\ patients\\ were\\ refractory\\ to\\ steroid\\ treatment\\.\\ only\\ the\\ resection\\ of\\ the\\ cysts\\ led\\ to\\ symptom\\ resolution\\,\\ thus\\ supporting\\ a\\ causal\\ relationship\\.\\ proposed\\ theories\\ of\\ the\\ pathophysiology\\ include\\ the\\ creation\\ of\\ antibodies\\ or\\ the\\ modification\\ of\\ red\\ blood\\ cells\\ by\\ the\\ teratoma\\ itself\\.\\ \ \(0\)\
\-\ therefore\\,\\ because\\ mature\\ teratomas\\ have\\ been\\ associated\\ with\\ aiha\\,\\ and\\ itp\\ is\\ of\\ a\\ similar\\ pathophysiologic\\ process\\,\\ i\\ suggest\\ that\\ it\\ is\\ not\\ unreasonable\\ to\\ consider\\ this\\ patient\\&\\#39\\;s\\ mature\\ teratoma\\ a\\ possible\\ etiology\\ of\\ her\\ episode\\ of\\ itp\\.\\ further\\ research\\ to\\ elucidate\\ the\\ relationship\\ between\\ itp\\ and\\ neoplasms\\ may\\ be\\ of\\ clinical\\ benefit\\ to\\ patients\\,\\ in\\ terms\\ of\\ treatment\\ and\\ neoplasm\\ detection\\.\\ \ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\ krauth\\ mt\\,\\ puthenparambil\\ j\\,\\ lechner\\ k\\.\\ paraneoplastic\\ autoimmune\\ thrombocytopenia\\ in\\ solid\\ tumors\\.\\ crit\\ rev\\ oncol\\ hematol\\.\\ 2012\\ jan\\;81\\(1\\)\\:75\\-81\\.\\ doi\\:\\ 10\\.1016\\/j\\.critrevonc\\.2011\\.02\\.004\\.\\ epub\\ 2011\\ apr\\ 22\\.\\ review\\.\ \(0\)\
\-\ 2\\.\\ buchwalter\\ cl\\,\\ miller\\ d\\,\\ jenison\\ el\\.\\ hemolytic\\ anemia\\ and\\ benign\\ pelvic\\ tumors\\.\\ a\\ case\\ report\\.\\ j\\ reprod\\ med\\.\\ 2001\\ apr\\;46\\(4\\)\\:401\\-4\\.\ \(0\)\
\-\ 3\\.\\ lancaster\\,\\ eric\\ \\(07\\/12\\/2011\\)\\.\\ \\"encephalitis\\ and\\ antibodies\\ to\\ synaptic\\ and\\ neuronal\\ cell\\ surface\\ proteins\\"\\.\\ neurology\\ \\(0028\\-3878\\)\\,\\ 77\\ \\(2\\)\\,\\ p\\.\\ 179\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ itp\\:\\ 0\\.39265390572546105\ \(0\)\
\-\ mature\\:\\ 0\\.22905398931475596\ \(0\)\
\-\ the\\:\\ 0\\.20081019709729772\ \(0\)\
\-\ her\\:\\ 0\\.20065915504286413\ \(0\)\
\-\ and\\:\\ 0\\.17698473189199165\ \(0\)\
\-\ teratoma\\:\\ 0\\.14813173893901352\ \(0\)\
\-\ as\\:\\ 0\\.1462363212612557\ \(0\)\
\-\ of\\:\\ 0\\.14247086196463318\ \(0\)\
\-\ she\\:\\ 0\\.14020946047204885\ \(0\)\
\-\ to\\:\\ 0\\.13917975770955743\ \(0\)\
\-\ rash\\:\\ 0\\.13855873660322215\ \(0\)\
\-\ aiha\\:\\ 0\\.1369726036670679\ \(0\)\
\-\ md\\:\\ 0\\.13664883093056676\ \(0\)\
\-\ teratomas\\:\\ 0\\.12896244748089997\ \(0\)\
\-\ paraneoplastic\\:\\ 0\\.10575025137401227\ \(0\)\
\-\ in\\:\\ 0\\.10120767651449543\ \(0\)\
\-\ been\\:\\ 0\\.09980103428720236\ \(0\)\
\-\ such\\:\\ 0\\.09641500318468776\ \(0\)\
\-\ was\\:\\ 0\\.08954936238776917\ \(0\)\
\-\ has\\:\\ 0\\.08802520265855947\ \(0\)\
\-\ is\\:\\ 0\\.08795912704426428\ \(0\)\
\-\ iud\\:\\ 0\\.08711827660377311\ \(0\)\
\-\ ovary\\:\\ 0\\.08380588690466169\ \(0\)\
\-\ dc\\:\\ 0\\.08275547425509742\ \(0\)\
\-\ cysts\\:\\ 0\\.0811286981042781\ \(0\)\
\-\ subsequent\\:\\ 0\\.08105162008215867\ \(0\)\
\-\ neoplasms\\:\\ 0\\.0798164129619634\ \(0\)\
\-\ it\\:\\ 0\\.07672509649526862\ \(0\)\
\-\ ovarian\\:\\ 0\\.07296941330760814\ \(0\)\
\-\ autoimmune\\:\\ 0\\.07186462519060098\ \(0\)\
\-\ fibroid\\:\\ 0\\.0704979704821041\ \(0\)\
\-\ be\\:\\ 0\\.0694893627291902\ \(0\)\
\-\ 2011\\:\\ 0\\.06927936830161108\ \(0\)\
\-\ hydrochloroquine\\:\\ 0\\.06848630183353395\ \(0\)\
\-\ cbcs\\:\\ 0\\.06848630183353395\ \(0\)\
\-\ us\\:\\ 0\\.06813033664396519\ \(0\)\
\-\ pelvic\\:\\ 0\\.0669521027897255\ \(0\)\
\-\ sneezing\\:\\ 0\\.06544231762091017\ \(0\)\
\-\ cystic\\:\\ 0\\.06447991680084018\ \(0\)\
\-\ antigens\\:\\ 0\\.06023859223873423\ \(0\)\
\-\ transfused\\:\\ 0\\.05807885106918208\ \(0\)\
\-\ associated\\:\\ 0\\.056429804425614224\ \(0\)\
\-\ uterus\\:\\ 0\\.056344632402227174\ \(0\)\
\-\ thrombocytopenia\\:\\ 0\\.055688095093905\ \(0\)\
\-\ dermoid\\:\\ 0\\.054261017618059154\ \(0\)\
\-\ hematology\\:\\ 0\\.05387759776884624\ \(0\)\
\-\ rheumatology\\:\\ 0\\.05387759776884624\ \(0\)\
\-\ have\\:\\ 0\\.05348343807977488\ \(0\)\
\-\ 39\\:\\ 0\\.0533830862128161\ \(0\)\
\-\ hemolytic\\:\\ 0\\.05335964145795737\ \(0\)\
\-\ antibodies\\:\\ 0\\.052875125687006135\ \(0\)\
\-\ causing\\:\\ 0\\.0527668245640565\ \(0\)\
\-\ apr\\:\\ 0\\.05241999307999452\ \(0\)\
\-\ hospitalized\\:\\ 0\\.05119990028840522\ \(0\)\
\-\ not\\:\\ 0\\.05071872860377427\ \(0\)\
\-\ igg\\:\\ 0\\.05048436971172906\ \(0\)\
\-\ where\\:\\ 0\\.05048285078629667\ \(0\)\
\-\ research\\:\\ 0\\.05015065304713058\ \(0\)\
\-\ exacerbated\\:\\ 0\\.048946898431310705\ \(0\)\
\-\ decided\\:\\ 0\\.048946898431310705\ \(0\)\
\-\ patient\\:\\ 0\\.048750739568566195\ \(0\)\
\-\ structures\\:\\ 0\\.04826767979560626\ \(0\)\
\-\ ovaries\\:\\ 0\\.04721626769781858\ \(0\)\
\-\ that\\:\\ 0\\.046460976890505906\ \(0\)\
\-\ pt\\:\\ 0\\.04622944704756814\ \(0\)\
\-\ led\\:\\ 0\\.04618624553440738\ \(0\)\
\-\ relationship\\:\\ 0\\.04545323558125989\ \(0\)\
\-\ 81\\:\\ 0\\.045280644329553116\ \(0\)\
\-\ fallopian\\:\\ 0\\.04511193186315764\ \(0\)\
\-\ might\\:\\ 0\\.04374317304913476\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.043731534178100155\ \(0\)\
\-\ ligaments\\:\\ 0\\.04320670282306027\ \(0\)\
\-\ encephalitis\\:\\ 0\\.042585903961422714\ \(0\)\
\-\ with\\:\\ 0\\.041928231844325925\ \(0\)\
\-\ found\\:\\ 0\\.04156447155736424\ \(0\)\
\-\ well\\:\\ 0\\.04147203341256397\ \(0\)\
\-\ an\\:\\ 0\\.040940223336316715\ \(0\)\
\-\ better\\:\\ 0\\.04042616279187057\ \(0\)\
\-\ suggested\\:\\ 0\\.04007691894737717\ \(0\)\
\-\ serial\\:\\ 0\\.03942369071003047\ \(0\)\
\-\ anemia\\:\\ 0\\.03934589323867179\ \(0\)\
\-\ episode\\:\\ 0\\.03919267590430553\ \(0\)\
\-\ on\\:\\ 0\\.03880154408134176\ \(0\)\
\-\ broad\\:\\ 0\\.03867977677703868\ \(0\)\
\-\ pain\\:\\ 0\\.038310792789782076\ \(0\)\
\-\ months\\:\\ 0\\.037391314962706104\ \(0\)\
\-\ due\\:\\ 0\\.036924812860803166\ \(0\)\
\-\ ligament\\:\\ 0\\.0368088169334667\ \(0\)\
\-\ this\\:\\ 0\\.036788497647888704\ \(0\)\
\-\ these\\:\\ 0\\.03627480216831676\ \(0\)\
\-\ idiopathic\\:\\ 0\\.036224909491534736\ \(0\)\
\-\ report\\:\\ 0\\.03607323991282864\ \(0\)\
\-\ worse\\:\\ 0\\.035875665647041345\ \(0\)\
\-\ review\\:\\ 0\\.03526725777448123\ \(0\)\
\-\ bleeding\\:\\ 0\\.03500226360051495\ \(0\)\
\-\ described\\:\\ 0\\.03474630510003112\ \(0\)\
\-\ bilateral\\:\\ 0\\.03452350402552754\ \(0\)\
\-\ etiology\\:\\ 0\\.03449878634677186\ \(0\)\
\-\ increase\\:\\ 0\\.034378021456331585\ \(0\)\
\-\ locating\\:\\ 0\\.034243150916766975\ \(0\)\
\-\ stabalized\\:\\ 0\\.034243150916766975\ \(0\)\
\-\ koshy\\:\\ 0\\.034243150916766975\ \(0\)\
\-\ jerky\\:\\ 0\\.034243150916766975\ \(0\)\
\-\ platetes\\:\\ 0\\.034243150916766975\ \(0\)\
\-\ krauth\\:\\ 0\\.034243150916766975\ \(0\)\
\-\ puthenparambil\\:\\ 0\\.034243150916766975\ \(0\)\
\-\ lechner\\:\\ 0\\.034243150916766975\ \(0\)\
\-\ buchwalter\\:\\ 0\\.034243150916766975\ \(0\)\
\-\ jenison\\:\\ 0\\.034243150916766975\ \(0\)\
\-\ reprod\\:\\ 0\\.034243150916766975\ \(0\)\
\-\ lancaster\\:\\ 0\\.034243150916766975\ \(0\)\
\-\ synaptic\\:\\ 0\\.034243150916766975\ \(0\)\
\-\ tube\\:\\ 0\\.03421996532785452\ \(0\)\
\-\ done\\:\\ 0\\.03406516832198259\ \(0\)\
\-\ arising\\:\\ 0\\.034026962698544445\ \(0\)\
\-\ formation\\:\\ 0\\.0339511298436372\ \(0\)\
\-\ stable\\:\\ 0\\.03387605532998195\ \(0\)\
\-\ can\\:\\ 0\\.03370970837012907\ \(0\)\
\-\ other\\:\\ 0\\.03335946950973576\ \(0\)\
\-\ includes\\:\\ 0\\.03330104606237961\ \(0\)\
\-\ 232\\:\\ 0\\.032721158810455085\ \(0\)\
\-\ abcesses\\:\\ 0\\.032721158810455085\ \(0\)\
\-\ fimbriae\\:\\ 0\\.032721158810455085\ \(0\)\
\-\ krukenberg\\:\\ 0\\.032721158810455085\ \(0\)\
\-\ tang\\:\\ 0\\.032721158810455085\ \(0\)\
\-\ scratching\\:\\ 0\\.032721158810455085\ \(0\)\
\-\ fingertip\\:\\ 0\\.032721158810455085\ \(0\)\
\-\ analogous\\:\\ 0\\.032721158810455085\ \(0\)\
\-\ crit\\:\\ 0\\.032721158810455085\ \(0\)\
\-\ hematol\\:\\ 0\\.032721158810455085\ \(0\)\
\-\ similar\\:\\ 0\\.03263917373794894\ \(0\)\
\-\ ct\\:\\ 0\\.032607665738217856\ \(0\)\
\-\ are\\:\\ 0\\.03250018655626128\ \(0\)\
\-\ for\\:\\ 0\\.032449729119234307\ \(0\)\
\-\ case\\:\\ 0\\.03227212902433156\ \(0\)\
\-\ incidental\\:\\ 0\\.031744379197985034\ \(0\)\
\-\ urgently\\:\\ 0\\.03164128822567901\ \(0\)\
\-\ dots\\:\\ 0\\.03164128822567901\ \(0\)\
\-\ glycoprotein\\:\\ 0\\.03164128822567901\ \(0\)\
\-\ creation\\:\\ 0\\.03164128822567901\ \(0\)\
\-\ pathophysiologic\\:\\ 0\\.03164128822567901\ \(0\)\
\-\ unreasonable\\:\\ 0\\.03164128822567901\ \(0\)\
\-\ elucidate\\:\\ 0\\.03164128822567901\ \(0\)\
\-\ course\\:\\ 0\\.03163274310668781\ \(0\)\
\-\ tumors\\:\\ 0\\.03149549268797896\ \(0\)\
\-\ after\\:\\ 0\\.031162575017340644\ \(0\)\
\-\ diagnosed\\:\\ 0\\.031021184109358797\ \(0\)\
\-\ reported\\:\\ 0\\.030844531516572172\ \(0\)\
\-\ follicle\\:\\ 0\\.030803675526378554\ \(0\)\
\-\ causal\\:\\ 0\\.030803675526378554\ \(0\)\
\-\ treatment\\:\\ 0\\.03059964214045704\ \(0\)\
\-\ malignant\\:\\ 0\\.03052709868917933\ \(0\)\
\-\ also\\:\\ 0\\.03021539243828674\ \(0\)\
\-\ eric\\:\\ 0\\.030119296119367114\ \(0\)\
\-\ because\\:\\ 0\\.029929866152689846\ \(0\)\
\-\ does\\:\\ 0\\.029605755873027217\ \(0\)\
\-\ visually\\:\\ 0\\.029540661575511093\ \(0\)\
\-\ lips\\:\\ 0\\.029540661575511093\ \(0\)\
\-\ thrombocytopenic\\:\\ 0\\.029540661575511093\ \(0\)\
\-\ immunologic\\:\\ 0\\.029540661575511093\ \(0\)\
\-\ given\\:\\ 0\\.02945916342851125\ \(0\)\
\-\ benign\\:\\ 0\\.02941780030016752\ \(0\)\
\-\ areas\\:\\ 0\\.029075121728329534\ \(0\)\
\-\ cystectomy\\:\\ 0\\.02903942553459104\ \(0\)\
\-\ peter\\:\\ 0\\.02903942553459104\ \(0\)\
\-\ theories\\:\\ 0\\.02903942553459104\ \(0\)\
\-\ epub\\:\\ 0\\.02903942553459104\ \(0\)\
\-\ el\\:\\ 0\\.02903942553459104\ \(0\)\
\-\ proteins\\:\\ 0\\.02903942553459104\ \(0\)\
\-\ 179\\:\\ 0\\.02903942553459104\ \(0\)\
\-\ followed\\:\\ 0\\.028919118425547636\ \(0\)\
\-\ cases\\:\\ 0\\.028804207169795877\ \(0\)\
\-\ dermoids\\:\\ 0\\.028597304013055217\ \(0\)\
\-\ got\\:\\ 0\\.028597304013055217\ \(0\)\
\-\ mt\\:\\ 0\\.028597304013055217\ \(0\)\
\-\ rev\\:\\ 0\\.028597304013055217\ \(0\)\
\-\ back\\:\\ 0\\.028561107338666968\ \(0\)\
\-\ density\\:\\ 0\\.02839730326656403\ \(0\)\
\-\ g1p1\\:\\ 0\\.028201812835290583\ \(0\)\
\-\ rh\\:\\ 0\\.028201812835290583\ \(0\)\
\-\ oncol\\:\\ 0\\.028201812835290583\ \(0\)\
\-\ finding\\:\\ 0\\.0281493952621969\ \(0\)\
\-\ iga\\:\\ 0\\.0278440475469525\ \(0\)\
\-\ any\\:\\ 0\\.027676864295595325\ \(0\)\
\-\ newbury\\:\\ 0\\.027517433428279142\ \(0\)\
\-\ resection\\:\\ 0\\.027451303459454984\ \(0\)\
\-\ approximately\\:\\ 0\\.02732539042322187\ \(0\)\
\-\ by\\:\\ 0\\.027278889960523103\ \(0\)\
\-\ pyosalpinx\\:\\ 0\\.027216977564603558\ \(0\)\
\-\ cramping\\:\\ 0\\.027216977564603558\ \(0\)\
\-\ ashley\\:\\ 0\\.027216977564603558\ \(0\)\
\-\ purpura\\:\\ 0\\.027216977564603558\ \(0\)\
\-\ receptor\\:\\ 0\\.027216977564603558\ \(0\)\
\-\ radiate\\:\\ 0\\.02693879888442312\ \(0\)\
\-\ igm\\:\\ 0\\.02693879888442312\ \(0\)\
\-\ supporting\\:\\ 0\\.02693879888442312\ \(0\)\
\-\ miller\\:\\ 0\\.02693879888442312\ \(0\)\
\-\ only\\:\\ 0\\.026754554005715216\ \(0\)\
\-\ understood\\:\\ 0\\.026679820728978686\ \(0\)\
\-\ epistaxis\\:\\ 0\\.026679820728978686\ \(0\)\
\-\ transvaginal\\:\\ 0\\.026437562843503067\ \(0\)\
\-\ modification\\:\\ 0\\.026437562843503067\ \(0\)\
\-\ stretching\\:\\ 0\\.02620999653999726\ \(0\)\
\-\ neuronal\\:\\ 0\\.02620999653999726\ \(0\)\
\-\ abdomen\\:\\ 0\\.026130311861531853\ \(0\)\
\-\ platelet\\:\\ 0\\.025995441321967246\ \(0\)\
\-\ refers\\:\\ 0\\.02579248949617999\ \(0\)\
\-\ msiii\\:\\ 0\\.02559995014420261\ \(0\)\
\-\ jan\\:\\ 0\\.02559995014420261\ \(0\)\
\-\ there\\:\\ 0\\.025559828668299818\ \(0\)\
\-\ projects\\:\\ 0\\.025416806778111225\ \(0\)\
\-\ manner\\:\\ 0\\.025416806778111225\ \(0\)\
\-\ buttocks\\:\\ 0\\.025416806778111225\ \(0\)\
\-\ however\\:\\ 0\\.02534732034103377\ \(0\)\
\-\ quadrants\\:\\ 0\\.02524218485586453\ \(0\)\
\-\ contributing\\:\\ 0\\.02507532652356529\ \(0\)\
\-\ pathophysiology\\:\\ 0\\.02507532652356529\ \(0\)\
\-\ displacing\\:\\ 0\\.02491557073719117\ \(0\)\
\-\ interestingly\\:\\ 0\\.02491557073719117\ \(0\)\
\-\ menstrual\\:\\ 0\\.024762337444902156\ \(0\)\
\-\ proposed\\:\\ 0\\.024762337444902156\ \(0\)\
\-\ apparently\\:\\ 0\\.024615114873515587\ \(0\)\
\-\ serous\\:\\ 0\\.024615114873515587\ \(0\)\
\-\ june\\:\\ 0\\.024615114873515587\ \(0\)\
\-\ occurrence\\:\\ 0\\.024615114873515587\ \(0\)\
\-\ mass\\:\\ 0\\.024536939873132553\ \(0\)\
\-\ 6cm\\:\\ 0\\.024473449215655353\ \(0\)\
\-\ follicular\\:\\ 0\\.024473449215655353\ \(0\)\
\-\ hydrosalpinx\\:\\ 0\\.024473449215655353\ \(0\)\
\-\ sore\\:\\ 0\\.024473449215655353\ \(0\)\
\-\ doi\\:\\ 0\\.024473449215655353\ \(0\)\
\-\ terms\\:\\ 0\\.024336936193335153\ \(0\)\
\-\ fibroids\\:\\ 0\\.024205214102618108\ \(0\)\
\-\ platelets\\:\\ 0\\.024205214102618108\ \(0\)\
\-\ patients\\:\\ 0\\.02409133558241998\ \(0\)\
\-\ malignancies\\:\\ 0\\.024077958037890715\ \(0\)\
\-\ prior\\:\\ 0\\.02396059409409553\ \(0\)\
\-\ faint\\:\\ 0\\.02395487506353366\ \(0\)\
\-\ pedunculated\\:\\ 0\\.02395487506353366\ \(0\)\
\-\ adnexa\\:\\ 0\\.02395487506353366\ \(0\)\
\-\ attributed\\:\\ 0\\.02395487506353366\ \(0\)\
\-\ office\\:\\ 0\\.02395487506353366\ \(0\)\
\-\ stay\\:\\ 0\\.02395487506353366\ \(0\)\
\-\ anatomical\\:\\ 0\\.0238357001524151\ \(0\)\
\-\ cl\\:\\ 0\\.023720192749552633\ \(0\)\
\-\ laparoscopic\\:\\ 0\\.023499323494034698\ \(0\)\
\-\ refractory\\:\\ 0\\.023499323494034698\ \(0\)\
\-\ clubbing\\:\\ 0\\.023393578630879278\ \(0\)\
\-\ 2012\\:\\ 0\\.023393578630879278\ \(0\)\
\-\ endometrioma\\:\\ 0\\.023290731254862328\ \(0\)\
\-\ acute\\:\\ 0\\.02316662134266812\ \(0\)\
\-\ mucinous\\:\\ 0\\.022905398931475595\ \(0\)\
\-\ whereas\\:\\ 0\\.022726617790629944\ \(0\)\
\-\ benefit\\:\\ 0\\.022726617790629944\ \(0\)\
\-\ variety\\:\\ 0\\.022640322164776558\ \(0\)\
\-\ polycystic\\:\\ 0\\.022640322164776558\ \(0\)\
\-\ neurology\\:\\ 0\\.022640322164776558\ \(0\)\
\-\ prednisone\\:\\ 0\\.02255596593157882\ \(0\)\
\-\ never\\:\\ 0\\.02255596593157882\ \(0\)\
\-\ imaging\\:\\ 0\\.02250592232273355\ \(0\)\
\-\ lutnick\\:\\ 0\\.022392736110341732\ \(0\)\
\-\ or\\:\\ 0\\.022347018393987856\ \(0\)\
\-\ detection\\:\\ 0\\.0223137080461032\ \(0\)\
\-\ 84\\:\\ 0\\.022236309543167236\ \(0\)\
\-\ leiomyoma\\:\\ 0\\.022236309543167236\ \(0\)\
\-\ croce\\:\\ 0\\.022160474753814188\ \(0\)\
\-\ flat\\:\\ 0\\.022160474753814188\ \(0\)\
\-\ lbs\\:\\ 0\\.022086141742597393\ \(0\)\
\-\ scarring\\:\\ 0\\.022086141742597393\ \(0\)\
\-\ iqbal\\:\\ 0\\.022086141742597393\ \(0\)\
\-\ were\\:\\ 0\\.02207498682557227\ \(0\)\
\-\ robert\\:\\ 0\\.022013252182427615\ \(0\)\
\-\ scott\\:\\ 0\\.022013252182427615\ \(0\)\
\-\ tirone\\:\\ 0\\.022013252182427615\ \(0\)\
\-\ classification\\:\\ 0\\.022013252182427615\ \(0\)\
\-\ syndromes\\:\\ 0\\.022013252182427615\ \(0\)\
\-\ lower\\:\\ 0\\.021883559095846945\ \(0\)\
\-\ transformation\\:\\ 0\\.02187158652456738\ \(0\)\
\-\ charles\\:\\ 0\\.021802709465476102\ \(0\)\
\-\ vaseem\\:\\ 0\\.021802709465476102\ \(0\)\
\-\ symptom\\:\\ 0\\.021802709465476102\ \(0\)\
\-\ itself\\:\\ 0\\.021735073502247182\ \(0\)\
\-\ cystadenoma\\:\\ 0\\.021668634698780127\ \(0\)\
\-\ attempted\\:\\ 0\\.021603351411530136\ \(0\)\
\-\ superiorly\\:\\ 0\\.021539184132732408\ \(0\)\
\-\ specifically\\:\\ 0\\.021539184132732408\ \(0\)\
\-\ rbc\\:\\ 0\\.021539184132732408\ \(0\)\
\-\ med\\:\\ 0\\.021539184132732408\ \(0\)\
\-\ separate\\:\\ 0\\.021476095346802743\ \(0\)\
\-\ large\\:\\ 0\\.021457389356594116\ \(0\)\
\-\ various\\:\\ 0\\.021414049398607676\ \(0\)\
\-\ 77\\:\\ 0\\.021414049398607676\ \(0\)\
\-\ adnexal\\:\\ 0\\.021353012372445693\ \(0\)\
\-\ had\\:\\ 0\\.021336928433633152\ \(0\)\
\-\ right\\:\\ 0\\.021297328118804332\ \(0\)\
\-\ morning\\:\\ 0\\.021233837461327128\ \(0\)\
\-\ noticed\\:\\ 0\\.021233837461327128\ \(0\)\
\-\ up\\:\\ 0\\.021183853108494143\ \(0\)\
\-\ remained\\:\\ 0\\.02117563948312716\ \(0\)\
\-\ randall\\:\\ 0\\.02111833005846466\ \(0\)\
\-\ loftus\\:\\ 0\\.02111833005846466\ \(0\)\
\-\ movements\\:\\ 0\\.02111833005846466\ \(0\)\
\-\ mouth\\:\\ 0\\.02111833005846466\ \(0\)\
\-\ consider\\:\\ 0\\.02106188246239084\ \(0\)\
\-\ touch\\:\\ 0\\.021006271157821322\ \(0\)\
\-\ dark\\:\\ 0\\.021006271157821322\ \(0\)\
\-\ contains\\:\\ 0\\.020844216017990004\ \(0\)\
\-\ contributors\\:\\ 0\\.020844216017990004\ \(0\)\
\-\ went\\:\\ 0\\.020791715939791306\ \(0\)\
\-\ krishnan\\:\\ 0\\.020688868563774356\ \(0\)\
\-\ kartha\\:\\ 0\\.020688868563774356\ \(0\)\
\-\ steroid\\:\\ 0\\.020638482647502288\ \(0\)\
\-\ height\\:\\ 0\\.02053969551460864\ \(0\)\
\-\ joanna\\:\\ 0\\.02053969551460864\ \(0\)\
\-\ garvey\\:\\ 0\\.02053969551460864\ \(0\)\
\-\ serghany\\:\\ 0\\.02053969551460864\ \(0\)\
\-\ geoffrey\\:\\ 0\\.020491260076115722\ \(0\)\
\-\ gerow\\:\\ 0\\.020491260076115722\ \(0\)\
\-\ here\\:\\ 0\\.020396224762026672\ \(0\)\
\-\ remains\\:\\ 0\\.020396224762026672\ \(0\)\
\-\ joseph\\:\\ 0\\.020258036357218717\ \(0\)\
\-\ 2001\\:\\ 0\\.020213081395935285\ \(0\)\
\-\ mechanism\\:\\ 0\\.020168658458520866\ \(0\)\
\-\ red\\:\\ 0\\.020168658458520866\ \(0\)\
\-\ factor\\:\\ 0\\.020081359305218243\ \(0\)\
\-\ confirm\\:\\ 0\\.020038459473688586\ \(0\)\
\-\ uterine\\:\\ 0\\.019996044396392382\ \(0\)\
\-\ undergo\\:\\ 0\\.019996044396392382\ \(0\)\
\-\ types\\:\\ 0\\.0199126255322597\ \(0\)\
\-\ thus\\:\\ 0\\.019672946619335895\ \(0\)\
\-\ 46\\:\\ 0\\.019672946619335895\ \(0\)\
\-\ arise\\:\\ 0\\.019596337952152765\ \(0\)\
\-\ destruction\\:\\ 0\\.019521261561509542\ \(0\)\
\-\ somewhat\\:\\ 0\\.019484279051509422\ \(0\)\
\-\ simple\\:\\ 0\\.01937546869663483\ \(0\)\
\-\ uncommon\\:\\ 0\\.01937546869663483\ \(0\)\
\-\ appreciated\\:\\ 0\\.01930464217273655\ \(0\)\
\-\ containing\\:\\ 0\\.019235127326811437\ \(0\)\
\-\ spread\\:\\ 0\\.019235127326811437\ \(0\)\
\-\ larger\\:\\ 0\\.01916687645746246\ \(0\)\
\-\ 31\\:\\ 0\\.019001488720442168\ \(0\)\
\-\ unlikely\\:\\ 0\\.018969267969803826\ \(0\)\
\-\ nature\\:\\ 0\\.018905644507653405\ \(0\)\
\-\ followup\\:\\ 0\\.018905644507653405\ \(0\)\
\-\ therefore\\:\\ 0\\.018874232655714775\ \(0\)\
\-\ involve\\:\\ 0\\.01884308148605005\ \(0\)\
\-\ states\\:\\ 0\\.018812186707519704\ \(0\)\
\-\ steroids\\:\\ 0\\.018812186707519704\ \(0\)\
\-\ repeat\\:\\ 0\\.018781544134075727\ \(0\)\
\-\ involves\\:\\ 0\\.01863197477023916\ \(0\)\
\-\ though\\:\\ 0\\.01860276299323008\ \(0\)\
\-\ unable\\:\\ 0\\.01854501270951469\ \(0\)\
\-\ rest\\:\\ 0\\.01851646736737669\ \(0\)\
\-\ sudden\\:\\ 0\\.01851646736737669\ \(0\)\
\-\ hr\\:\\ 0\\.01840440846673335\ \(0\)\
\-\ discharged\\:\\ 0\\.018376908751054525\ \(0\)\
\-\ lack\\:\\ 0\\.01832250643068188\ \(0\)\
\-\ subsequently\\:\\ 0\\.018268881312941868\ \(0\)\
\-\ disease\\:\\ 0\\.017976362132359258\ \(0\)\
\-\ displaced\\:\\ 0\\.01788939738502775\ \(0\)\
\-\ off\\:\\ 0\\.01788939738502775\ \(0\)\
\-\ cbc\\:\\ 0\\.017865412035677635\ \(0\)\
\-\ surface\\:\\ 0\\.017865412035677635\ \(0\)\
\-\ count\\:\\ 0\\.017678854668076237\ \(0\)\
\-\ suspected\\:\\ 0\\.01754477990138026\ \(0\)\
\-\ round\\:\\ 0\\.01754477990138026\ \(0\)\
\-\ displacement\\:\\ 0\\.0174579854125583\ \(0\)\
\-\ work\\:\\ 0\\.0174579854125583\ \(0\)\
\-\ suggestive\\:\\ 0\\.01743659678260062\ \(0\)\
\-\ suggest\\:\\ 0\\.01739418170530441\ \(0\)\
\-\ bp\\:\\ 0\\.01737315255001556\ \(0\)\
\-\ resolution\\:\\ 0\\.01737315255001556\ \(0\)\
\-\ condition\\:\\ 0\\.01710998266392726\ \(0\)\
\-\ arm\\:\\ 0\\.01709048290889882\ \(0\)\
\-\ references\\:\\ 0\\.017071083928247927\ \(0\)\
\-\ from\\:\\ 0\\.017008225684277616\ \(0\)\
\-\ same\\:\\ 0\\.016938027664990973\ \(0\)\
\-\ prominent\\:\\ 0\\.016864060849999196\ \(0\)\
\-\ pathology\\:\\ 0\\.016809526800251676\ \(0\)\
\-\ initially\\:\\ 0\\.01679152343527754\ \(0\)\
\-\ considered\\:\\ 0\\.016685279709153546\ \(0\)\
\-\ reports\\:\\ 0\\.016650523031189805\ \(0\)\
\-\ vessels\\:\\ 0\\.016616085226325114\ \(0\)\
\-\ circumscribed\\:\\ 0\\.016581960496745866\ \(0\)\
\-\ cells\\:\\ 0\\.016497981727915837\ \(0\)\
\-\ symptomatic\\:\\ 0\\.016464909316604187\ \(0\)\
\-\ solid\\:\\ 0\\.016415840717208776\ \(0\)\
\-\ vs\\:\\ 0\\.016335458750556465\ \(0\)\
\-\ pressure\\:\\ 0\\.016303781816565433\ \(0\)\
\-\ change\\:\\ 0\\.01622573962085562\ \(0\)\
\-\ at\\:\\ 0\\.016175498311513468\ \(0\)\
\-\ note\\:\\ 0\\.01611913667233779\ \(0\)\
\-\ midline\\:\\ 0\\.01610415184444763\ \(0\)\
\-\ process\\:\\ 0\\.016059552970476662\ \(0\)\
\-\ malignancy\\:\\ 0\\.016030112079151188\ \(0\)\
\-\ er\\:\\ 0\\.016015477774449446\ \(0\)\
\-\ classic\\:\\ 0\\.016015477774449446\ \(0\)\
\-\ commonly\\:\\ 0\\.015844176824198107\ \(0\)\
\-\ confirmed\\:\\ 0\\.015788770734859837\ \(0\)\
\-\ tender\\:\\ 0\\.015653731194168567\ \(0\)\
\-\ breast\\:\\ 0\\.015549091821936029\ \(0\)\
\-\ clear\\:\\ 0\\.01552338148579629\ \(0\)\
\-\ since\\:\\ 0\\.015510592054679398\ \(0\)\
\-\ very\\:\\ 0\\.015360424254109556\ \(0\)\
\-\ portion\\:\\ 0\\.015311674290969295\ \(0\)\
\-\ they\\:\\ 0\\.015299585087600338\ \(0\)\
\-\ would\\:\\ 0\\.015157472428322305\ \(0\)\
\-\ palpable\\:\\ 0\\.015043021660062595\ \(0\)\
\-\ typically\\:\\ 0\\.015031766196152645\ \(0\)\
\-\ effect\\:\\ 0\\.015020544380914444\ \(0\)\
\-\ weight\\:\\ 0\\.01493195751082338\ \(0\)\
\-\ neoplasm\\:\\ 0\\.014617217845955495\ \(0\)\
\-\ elevated\\:\\ 0\\.014597144566025894\ \(0\)\
\-\ masses\\:\\ 0\\.014577178059366718\ \(0\)\
\-\ although\\:\\ 0\\.014577178059366718\ \(0\)\
\-\ possible\\:\\ 0\\.014508119972839292\ \(0\)\
\-\ size\\:\\ 0\\.014498357433132245\ \(0\)\
\-\ inflammatory\\:\\ 0\\.01447890819583021\ \(0\)\
\-\ palpation\\:\\ 0\\.014440309455707599\ \(0\)\
\-\ three\\:\\ 0\\.014373702230730631\ \(0\)\
\-\ bilaterally\\:\\ 0\\.014280553669333484\ \(0\)\
\-\ surrounding\\:\\ 0\\.014280553669333484\ \(0\)\
\-\ flow\\:\\ 0\\.014262198158911226\ \(0\)\
\-\ showed\\:\\ 0\\.014262198158911226\ \(0\)\
\-\ cancer\\:\\ 0\\.014262198158911226\ \(0\)\
\-\ should\\:\\ 0\\.013971614876846495\ \(0\)\
\-\ further\\:\\ 0\\.013946280510252458\ \(0\)\
\-\ past\\:\\ 0\\.013937873576387842\ \(0\)\
\-\ differential\\:\\ 0\\.013912765159014453\ \(0\)\
\-\ between\\:\\ 0\\.013912765159014453\ \(0\)\
\-\ adjacent\\:\\ 0\\.013879546407693757\ \(0\)\
\-\ area\\:\\ 0\\.013871287450783304\ \(0\)\
\-\ onset\\:\\ 0\\.013749535337777367\ \(0\)\
\-\ examination\\:\\ 0\\.013701919125477463\ \(0\)\
\-\ day\\:\\ 0\\.013639356103874107\ \(0\)\
\-\ clinical\\:\\ 0\\.013570197034760421\ \(0\)\
\-\ days\\:\\ 0\\.01355499987067637\ \(0\)\
\-\ yo\\:\\ 0\\.013377277002857608\ \(0\)\
\-\ fat\\:\\ 0\\.013319857995675971\ \(0\)\
\-\ negative\\:\\ 0\\.013256294389126932\ \(0\)\
\-\ lung\\:\\ 0\\.01302543392621576\ \(0\)\
\-\ when\\:\\ 0\\.01293435195046107\ \(0\)\
\-\ syndrome\\:\\ 0\\.012908729363591429\ \(0\)\
\-\ region\\:\\ 0\\.012807952991434743\ \(0\)\
\-\ carcinoma\\:\\ 0\\.012807952991434743\ \(0\)\
\-\ likely\\:\\ 0\\.012795544073021704\ \(0\)\
\-\ include\\:\\ 0\\.012740206052599328\ \(0\)\
\-\ two\\:\\ 0\\.012715870833483547\ \(0\)\
\-\ chronic\\:\\ 0\\.012709811599881325\ \(0\)\
\-\ secondary\\:\\ 0\\.012691692364048527\ \(0\)\
\-\ presented\\:\\ 0\\.012486521386909907\ \(0\)\
\-\ if\\:\\ 0\\.012441158968974624\ \(0\)\
\-\ blood\\:\\ 0\\.012435527018328448\ \(0\)\
\-\ cyst\\:\\ 0\\.012352046311543241\ \(0\)\
\-\ cell\\:\\ 0\\.012248901436465186\ \(0\)\
\-\ both\\:\\ 0\\.011940627516400423\ \(0\)\
\-\ metastatic\\:\\ 0\\.011743651464239635\ \(0\)\
\-\ symptoms\\:\\ 0\\.011715673488245629\ \(0\)\
\-\ abdominal\\:\\ 0\\.01171103069927835\ \(0\)\
\-\ physical\\:\\ 0\\.011610315783504405\ \(0\)\
\-\ increased\\:\\ 0\\.01157882864763558\ \(0\)\
\-\ soft\\:\\ 0\\.011399526688396423\ \(0\)\
\-\ noted\\:\\ 0\\.011352843623828017\ \(0\)\
\-\ tissue\\:\\ 0\\.011232482690490542\ \(0\)\
\-\ woman\\:\\ 0\\.01115166806420499\ \(0\)\
\-\ demonstrate\\:\\ 0\\.011131733368380524\ \(0\)\
\-\ may\\:\\ 0\\.010775414311769638\ \(0\)\
\-\ findings\\:\\ 0\\.0105678973356459\ \(0\)\
\-\ images\\:\\ 0\\.009904678446750952\ \(0\)\
\-\ within\\:\\ 0\\.0098619089631474\ \(0\)\
\-\ which\\:\\ 0\\.009736448901869702\ \(0\)\
\-\ left\\:\\ 0\\.007304249831860562\ \(0\)\
\-\ no\\:\\ 0\\.006963081405521312\ \(0\)\
